Imagin Medical Overview
Get informed when a big investor buys or sells
+ Follow27.78%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for IME.CN is 27.78%. That is above the sector sector average of 11.64%. Investors often review this figure alongside Imagin Medical's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, IME.CN currently prints 27.78% for ROE, while the sector average sits near 11.64%. That is roughly 138.7% above the sector mean. Large gaps often invite a closer look at Imagin Medical's growth, margins, and balance sheet.
Return on Equity shows how effectively Imagin Medical converts resources into returns. At 27.78%, IME.CN may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting IME.CN's ROE (27.78%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
